0002094607-25-000001.txt : 20251103 0002094607-25-000001.hdr.sgml : 20251103 20251031173914 ACCESSION NUMBER: 0002094607-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251103 DATE AS OF CHANGE: 20251031 EFFECTIVENESS DATE: 20251103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oxbridge Clinical Inc. CENTRAL INDEX KEY: 0002094607 ORGANIZATION NAME: EIN: 922428473 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562770 FILM NUMBER: 251441613 BUSINESS ADDRESS: STREET 1: 75 KNEELAND ST 14TH FL CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 617-512-5730 MAIL ADDRESS: STREET 1: 75 KNEELAND ST 14TH FL CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0002094607 Oxbridge Clinical Inc. 75 KNEELAND ST 14TH FL BOSTON MA MASSACHUSETTS 02111 617-512-5730 DELAWARE None None Corporation true 2023 Guilio Deangeli 75 Kneeland St 14th Fl Boston MA MASSACHUSETTS 02111 Executive Officer Director Biotechnology Decline to Disclose 06b false 2025-10-08 false true false 0 4500000 4500000 0 false 3 0 0 0 false Oxbridge Clinical Inc. Guilio Deangeli Guilio Deangeli CEO 2025-10-31